31 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Women with in HIV-AIDS ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... advanced Chagas cardiomyopathy ... Trypanosomiasis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Encephalitis in HIV-AIDS ... #Encephalitis #IDSA ... #Prevention #Treatment
Oral HPV-Associated Papillomatosis in AIDS - A 36-year-old man who had the acquired immunodeficiency syndrome (AIDS)
Oral HPV-Associated ... Papillomatosis in AIDS ... immunodeficiency syndrome ... (AIDS) with Kaposi ... #AIDS #NEJM
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Summary Acute AIDP ... Campylobacter jejuni - HIV ... tachycardia, reversible cardiomyopathy ... GQ1b IgG Antibody associated ... Treatment: • Plasmapheresis
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Disease (MCD) in HIV-AIDS ... recommended for KS treatment ... KaposiSarcoma #Castlemans #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Infections in HIV-AIDS ... • Continue treatment ... #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... for effective treatment ... candida #mucosal #IDSA ... #Prevention #Treatment